129 related articles for article (PubMed ID: 7448415)
1. Studies on the inhibition of ellagic acid-activated Hageman factor (factor XII) and Hageman factor fragments.
Ratnoff OD
Blood; 1981 Jan; 57(1):55-8. PubMed ID: 7448415
[TBL] [Abstract][Full Text] [Related]
2. The relative amidolytic activity of Hageman factor (factor XII) and its fragments. The effect of high-molecular-weight kininogen and kaolin.
Ratnoff OD
J Lab Clin Med; 1980 Aug; 96(2):267-77. PubMed ID: 7400662
[TBL] [Abstract][Full Text] [Related]
3. The evolution of clot-promoting and amidolytic activities in mixtures of Hageman factor (factor XII) and ellagic acid.
Ratnoff OD; Saito H
J Lab Clin Med; 1982 Aug; 100(2):248-60. PubMed ID: 7097109
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ellagic acid-activated Hageman factor (factor XII) and Hageman factor fragments by popcorn inhibitor.
Ratnoff OD; Moneme V
Proc Soc Exp Biol Med; 1981 Feb; 166(2):297-9. PubMed ID: 7208489
[No Abstract] [Full Text] [Related]
5. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.
Joist JH; Cowan JF; Khan M
J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory action of amyloid precursor protein against human Hageman factor (factor XII).
Niwano H; Embury PB; Greenberg BD; Ratnoff OD
J Lab Clin Med; 1995 Feb; 125(2):251-6. PubMed ID: 7844473
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
Dumenco LL; Everson B; Culp LA; Ratnoff OD
J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Hageman factor (factor XII) by popcorn inhibitor.
Kambhu SA; Ratnoff OD; Everson B
J Lab Clin Med; 1985 May; 105(5):625-8. PubMed ID: 3989356
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the activation of Hageman factor (factor XII) by complement subcomponent C1q.
Rehmus EH; Greene BM; Everson BA; Ratnoff OD
J Clin Invest; 1987 Aug; 80(2):516-21. PubMed ID: 3038961
[TBL] [Abstract][Full Text] [Related]
10. The regulation of human factor XIIa by plasma proteinase inhibitors.
Pixley RA; Schapira M; Colman RW
J Biol Chem; 1985 Feb; 260(3):1723-9. PubMed ID: 2578463
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody that inhibits activation of human Hageman factor (factor XII).
Small EJ; Katzmann JA; Tracy RP; Ratnoff OD; Goldsmith GH; Everson B
Blood; 1985 Jan; 65(1):202-10. PubMed ID: 3965048
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the activation of Hageman factor (factor XII) by extracts of Schistosoma mansoni.
Foster CB; Flanigan TP; DeStigter KK; Blanton R; Dumenco LL; Gallagher C; Ratnoff OD
J Lab Clin Med; 1992 Nov; 120(5):735-9. PubMed ID: 1431502
[TBL] [Abstract][Full Text] [Related]
13. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
España F; Ratnoff OD
J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the activation of hageman factor (factor XII) by eosinophils and eosinophilic constituents.
Ratnoff OD; Gleich GJ; Shurin SB; Kazura J; Everson B; Embury P
Am J Hematol; 1993 Jan; 42(1):138-45. PubMed ID: 8416290
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the activation of Hageman factor (factor XII) by beta 2-glycoprotein I.
Henry ML; Everson B; Ratnoff OD
J Lab Clin Med; 1988 May; 111(5):519-23. PubMed ID: 3361230
[TBL] [Abstract][Full Text] [Related]
16. Evidence that Fitzgerald factor counteracts inhibition by kaolin or ellagic acid of the amidolytic properties of a plasma kallikrein.
Ratnoff OD; Saito H
Blood; 1976 Feb; 47(2):243-51. PubMed ID: 1244922
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the activation of Hageman factor (factor XII) by aprotinin (Trasylol).
Laurel MT; Ratnoff OD; Everson B
J Lab Clin Med; 1992 May; 119(5):580-5. PubMed ID: 1374787
[TBL] [Abstract][Full Text] [Related]
18. The effect of C1 inhibitor upon Hageman factor autoactivation.
Weiss R; Silverberg M; Kaplan AP
Blood; 1986 Jul; 68(1):239-43. PubMed ID: 3487356
[TBL] [Abstract][Full Text] [Related]
19. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
Ratnoff OD; Saito H
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay.
Kaplan AP; Gruber B; Harpel PC
Blood; 1985 Sep; 66(3):636-41. PubMed ID: 3875374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
